心力衰竭国内外指南浅析

Highlights of Cardiology Guidelines for the Diagnosis and Treatment of Heart Failure in Abroad and China

近几年随着循证医学证据的不断增加,各国对心力衰竭指南进行了更新。主要是2012年欧洲心脏病学会(ESC)与心衰学会公布的心力衰竭新指南、2011年澳大利亚和新西兰慢性心力衰竭诊治指南、2010年英国国立健康与临床优化研究所(NICE)慢性心力衰竭诊治指南、2009美国心脏病学会(ACC)/美国心脏协会(AHA)实践指南工作组成人心力衰竭诊疗指南及2010年我国的急性心力衰竭指南等。各国指南对心力衰竭的诊断和治疗都提出了具体的意见和建议,其中不乏亮点,如对慢性心力衰竭患者更加重视血运重建的治疗作用、推荐心力衰竭治疗的一种新型β受体阻滞剂奈必洛尔等等。我们对以上几个指南做了浅要分析,以取长补短更规范的诊治心力衰竭患者。

A large number of Guidelines for the diagnosis and treatment of heart failure have been issued in recent years by the ESC as well as by other societies and organizations （ACC/AHA, NICE, Australia and New Zealand, China, etc. ）. Guidelines summarize and evaluate all available evidence on diagnosis and treatment of acute and chronic heart failure in re- cent years. We summarize the highlights of the guidelines of ESC ACC/AHA NICE, Australia and China, with the aim of assisting Chinese physicians in selecting the best management strategies for every given patients, taking into account of the outcome as well as the risk--benefit ratio of particular diagnostic and therapeutic means.